ACE and hypertensive disorder: The percentage of hypertension prescriptions containing ‘contraindicated’ combination of angiotensin-converting-enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) was 0.7% (n = 478) in poor prescribers and 0.5% (n = 232) in good prescribers.